11,884 Views 55 Download 1 Crossref ABSTRACT Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) exhibit not only hypoglycemic effects but also protective effects against nonalcoholic fatty liver disease and cardiovascular diseases, conditions that are associated with dyslipidemia
doi: 10.1016/j.pathophys.2018.06.001 7 GBD 2016 Dementia Collaborators (2019)
Synthesis of ROS-sensitive polymers (P3) To a solution of ROS sensitive compound (2,2-(propane-2,2-diylbis(sulfanediyl))bis(ehan-1-ol)) (0.26 g, 1.35 mmol) in anhydrous DMF (5 ml), 1,2,4,5-cyclohexanetetracarboxylic dianhydride (0.31 g, 1.41 mmol) was quickly added into the solution
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
GHK-Cu steps in to restart that engine
Most patients see meaningful regrowth after completing 3 cycles, approximately 3 months